Bridging the gap: a Canadian perspective on translational kidney research

Canadian Journal of Kidney Health and Disease
Amber O MolnarVictor L Jensen

Abstract

Chronic kidney disease affects approximately 3 million Canadians. Ongoing investment in high quality kidney research is needed to improve the care of patients with kidney disease. The barriers to translating such research are discussed in this review. Personal knowledge, research funding body websites, and published reports. In this review, we discuss the meaning of the term translational research and present some of the programs aimed at ensuring efficient translation of scientific discoveries with a discussion of the barriers to translation. We highlight some successes and barriers to kidney research translation using recent examples of research in Canadian nephrology. We present the following examples of kidney research: (1) research aimed at identifying the causative genes for inherited kidney diseases; (2) recent discoveries in cell-based therapies for kidney disease; (3) an examination of the impact of acute kidney injury in renal transplant patients; and (4) the development of a kidney failure risk equation to improve prognosis accuracy. This review focuses on research conducted by the authors. The process of research translation is prolonged and challenging and therefore requires resources, patience, and careful plannin...Continue Reading

References

Apr 4, 1974·The New England Journal of Medicine·S Wolf
Apr 2, 1999·Science·M F PittengerD R Marshak
Jun 7, 2000·The Journal of Clinical Investigation·T MuroharaT Imaizumi
Mar 14, 2003·JAMA : the Journal of the American Medical Association·Nancy S SungDavid Rimoin
May 7, 2003·The American Journal of Medicine·Despina G Contopoulos-IoannidisJohn P A Ioannidis
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
May 25, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Jin-Ho ChoiDuk-Kyung Kim
Jun 2, 2005·American Journal of Physiology. Renal Physiology·Christopher T ChanSubodh Verma
Oct 4, 2005·Journal of Molecular and Cellular Cardiology·Carmen UrbichStefanie Dimmeler
Oct 6, 2006·Molecular Biology of the Cell·Oliver E BlacqueMichel R Leroux
Jan 10, 2008·JAMA : the Journal of the American Medical Association·Steven H Woolf
Apr 11, 2008·Critical Care Medicine·Stanislao MorgeraHans H Neumayer
May 14, 2008·Archives of Internal Medicine·Chirag R ParikhHarlan M Krumholz
May 30, 2008·Injury·N C KeramarisP V Giannoudis
Nov 21, 2008·Journal of the American Society of Nephrology : JASN·Areef IshaniAllan J Collins
Jul 18, 2009·Journal of the American Society of Nephrology : JASN·Elizabeth VergheseJames A Deane
Sep 17, 2009·JAMA : the Journal of the American Medical Association·Ron WaldUNKNOWN University of Toronto Acute Kidney Injury Research Group
Oct 31, 2009·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Kate Baker, Philip L Beales
Apr 13, 2010·Lancet·Friedhelm Hildebrandt
Jun 19, 2010·Journal of the American Society of Nephrology : JASN·Duangpen ThirabanjasakPaul Scott Thorner
Sep 8, 2010·American Journal of Human Genetics·Christian GilissenHan G Brunner
Dec 8, 2010·Clinical and Investigative Medicine. Médecine Clinique Et Experimentale·Kevin D BurnsAdeera Levin
Dec 15, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Brian C Drolet, Nancy M Lorenzi
Apr 9, 2011·American Journal of Human Genetics·Pleasantine MillDavid J Amor
Apr 13, 2011·JAMA : the Journal of the American Medical Association·Navdeep TangriAndrew S Levey
May 21, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Darren A YuenChristopher T Chan
Nov 10, 2011·Clinical Transplantation·Motonobu NakamuraSatoshi Teraoka
Dec 14, 2011·Kidney International·Ion D BucaloiuRobert M Perkins
Jan 10, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Anita MehrotraJohn S Gill

❮ Previous
Next ❯

Software Mentioned

Excel
KRESCENT

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Canadian Journal of Kidney Health and Disease
Amber O MolnarKara Schick-Makaroff
Seminars in Nephrology
Blake LernerNavdeep Tangri
Journal of the American Society of Nephrology : JASN
Paul M Palevsky, Steven D Weisbord
Current Opinion in Nephrology and Hypertension
Michael Heung, Lakhmir S Chawla
© 2021 Meta ULC. All rights reserved